A phase 1b study of erlotinib and momelotinib for the treatment of EGFR-mutated, tyrosine kinase inhibitor-naive metastatic non-small cell lung cancer
Titel:
A phase 1b study of erlotinib and momelotinib for the treatment of EGFR-mutated, tyrosine kinase inhibitor-naive metastatic non-small cell lung cancer
Auteur:
Padda, Sukhmani K. Reckamp, Karen L. Koczywas, Marianna Neal, Joel W. Kawashima, Jun Kong, Shengchun Huang, Daniel B. Kowalski, Mark Wakelee, Heather A.